Hb S (HBB: c.20A>T) Characteristics by High Performance Liquid Chromatography in Patients with Sickle Cell Disease Receiving the Novel Agent Voxelotor.
Sign Up to like & getrecommendations! Published in 2021 at "Hemoglobin"
DOI: 10.1080/03630269.2020.1788074
Abstract: Voxelotor is a novel agent in the management of sickle cell disease. It is an inhibitor of Hb S (HBB: c.20A>T) polymerization that reversibly binds to hemoglobin (Hb), stabilizing it in the oxygenated state that… read more here.
Keywords: voxelotor; cell disease; novel agent; hbb 20a ... See more keywords